Skip to content

Clinical Performance Assessment of Two Silicone Hydrogel Daily Disposable Contact Lenses

Clinical Performance Assessment of Two Silicone Hydrogel Daily Disposable Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05725317
Enrollment
114
Registered
2023-02-13
Start date
2023-06-02
Completion date
2023-06-27
Last updated
2024-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia, Refractive Errors

Brief summary

The purpose of this study is to assess the overall clinical performance of a contact lens made with a modified manufacturing process.

Detailed description

The expected duration of subject participation in the study is approximately 4 days with 2 scheduled visits.

Interventions

DEVICELID220365 contact lens

Investigational delefilcon A spherical contact lens made with a modified manufacturing process

DEVICELID006961 contact lens

Commercially available delefilcon A spherical contact lens

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Key Inclusion Criteria: * Successful wearer of spherical soft contact lenses of the same brand in both eyes for a minimum of 5 days per week and 10 hours per day during the past 3 months. * Manifest cylinder equal to or less than 0.75 diopter (D) in each eye. * Best corrected visual acuity (BCVA) better than or equal to 0.10 logMAR in each eye. * Other protocol-specified inclusion criteria may apply. Key

Exclusion criteria

* Any use of topical ocular medications and artificial tear or rewetting drops that would require instillation during study participation. * Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment. * Habitual monovision or multifocal contact lens wearers. * Other protocol-specified

Design outcomes

Primary

MeasureTime frameDescription
Least Squares Mean Distance Visual Acuity (VA) With Study Lenses at Day 4Day 4VA was assessed for each eye individually at a distance of 4 meters with contact lenses in place using a letter chart. VA was measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity.

Countries

United States

Participant flow

Recruitment details

Participants were recruited from 7 investigative sites located in the United States.

Pre-assignment details

Of the 114 enrolled, 1 participant was exited from the study prior to randomization as a screen failure. This reporting group includes all randomized participants (113).

Participants by arm

ArmCount
LID220365 (OD) / LID006961 (OS)
LID220365 contact lens worn in the right eye (OD), with LID006961 contact lens worn in the left eye (OS), as randomized, for four days. A fresh pair of lenses was worn each day.
56
LID006961 (OD) / LID220365 (OS)
LID006961 contact lens worn in the right eye (OD), with LID220365 contact lens worn in the left eye (OS), as randomized, for four days. A fresh pair of lenses was worn each day.
57
Total113

Baseline characteristics

CharacteristicLID006961 (OD) / LID220365 (OS)LID220365 (OD) / LID006961 (OS)Total
Age, Continuous33.8 years
STANDARD_DEVIATION 7.9
33.2 years
STANDARD_DEVIATION 8.2
33.5 years
STANDARD_DEVIATION 8
Race/Ethnicity, Customized
American Indian or Alaska Native
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Asian
4 Participants7 Participants11 Participants
Race/Ethnicity, Customized
Black or African American
4 Participants2 Participants6 Participants
Race/Ethnicity, Customized
Hispanic or Latino
9 Participants5 Participants14 Participants
Race/Ethnicity, Customized
Multi-racial
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Not Hispanic or Latino
48 Participants51 Participants99 Participants
Race/Ethnicity, Customized
Other
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
White
46 Participants47 Participants93 Participants
Sex: Female, Male
Female
38 Participants38 Participants76 Participants
Sex: Female, Male
Male
19 Participants18 Participants37 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 1130 / 1130 / 1130 / 113
other
Total, other adverse events
0 / 1130 / 1130 / 1130 / 113
serious
Total, serious adverse events
0 / 1130 / 1130 / 1130 / 113

Outcome results

Primary

Least Squares Mean Distance Visual Acuity (VA) With Study Lenses at Day 4

VA was assessed for each eye individually at a distance of 4 meters with contact lenses in place using a letter chart. VA was measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity.

Time frame: Day 4

Population: Full Analysis Set

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
LID220365Least Squares Mean Distance Visual Acuity (VA) With Study Lenses at Day 4-0.13 logMARStandard Error 0.006
LID006961Least Squares Mean Distance Visual Acuity (VA) With Study Lenses at Day 4-0.13 logMARStandard Error 0.006

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026